Home » Medical Devices » Hemostasis And Tissue Sealing Agents Market

Hemostasis And Tissue Sealing Agents Market By Product (Hemostats, Sealants, Adhesives) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Price: $4999

Published: | Report ID: 6689 | Report Format : PDF

Industry Outlook

Hemostasis and tissue sealing agents are materials used to restrict bleeding or hemorrhage caused by injuries or during surgical procedures. Perpetual innovation in the field of hemostasis and an increased volume of surgical procedures together drive the growth of this market. Growth in the prevalence of chronic diseases and the geriatric population has led to an increase in the number of surgeries performed worldwide. Conditions such as cardiovascular diseases, hernias, ophthalmic conditions, gynecological and urological conditions, and burns frequently require surgical intervention, wherein hemostats and tissue sealants are required.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Hemostats and tissue-sealing agents are used for the prevention of blood loss and have wide applications in surgical procedures. Hemostats are frequently used in minimally invasive surgical interventions. As a result, the growing trend of minimally invasive surgery adoption promotes the growth of the hemostasis and tissue sealing agents market. However, the lack of widespread and appropriate reimbursement for these products restrains the desired market growth.

Market Synopsis

Increasing the Number of Surgical Procedures to Accelerate Market Growth

Based on the product types, the global hemostasis and tissue sealing agents market is classified into hemostasis products, sealants, and adhesives. The hemostats segment is further classified as mechanical, active, and flowable hemostats; sealants as fibrin and synthetic sealants; and adhesives as cyanoacrylate, albumin, and glutaraldehyde. Among these, the hemostats segment enjoys the largest revenue share in the global market as these products offer greater cost efficiency, quick sealing properties, and low tissue reactivity. Sealants and adhesives will witness rapid market growth during the forecast period on the ground of their proven efficiency in preventing blood loss from surgical sites in combination with other drugs. The growing demand for these products over surgical sutures is due to their faster application rate, less invasion, lower risk of infection, and lesser exudate discharge. The market players engaged in the production of hemostats and tissue sealing agents are engaged in the production of novel agents that have wider applicability than the existing ones. Furthermore, efforts are also being made to bring innovation through the introduction of natural sealants, which will have better bioavailability and therefore witness fast market growth.

North America and Asia Pacific to Remain the Most Prominent Regional Markets

At present, North America has the largest revenue contribution in the global hemostasis and tissue sealing agents market. The high prevalence of chronic diseases such as diabetes and cancer in the region promotes the dominance of the North American market. Europe is estimated to be the second largest regional market as the region witnesses swift approval of novel and technologically advanced products in the healthcare system, along with a greater incidence of surgical procedures. Aggressive marketing of novel surgical products to surgeons also facilitates the dominance of Europe and North America on the global front. Additionally, Asia Pacific is anticipated to undergo the fastest market growth during the forecast period from 2018 to 2026. Favorable government policies and increasing healthcare expenditure, along with a large potential patient pool, contribute to the swift pace of the Asia-Pacific market. The burgeoning medical tourism industry in the region also supports market growth in Asia Pacific.

Periods of History and Forecast

This research report presents the analysis of each considered segment for the period from 2016 to 2026, using 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

This report on the global hemostasis and tissue sealing agents market offers both qualitative and quantitative analysis of the industry in terms of market size and forecast and the prevalent market dynamics. For the purpose of this study, the global hemostasis and tissue sealing agents market is studied for product types and geography.

The market dynamics in the hemostasis and tissue sealing agents industry are assessed for a vivid understanding of the industry’s development. The dynamics of the global hemostasis and tissue sealing agents market are classified into three categories: drivers, challenges, and opportunities. The report also includes a competitive analysis of the prominent players in the global hemostasis and tissue-sealing agent markets. The profiles of such players are also assessed in the study based on their business overview, product portfolio, financial information, and key developments. The prime players operating in the global hemostasis and tissue sealing agents market are Baxter International, Inc., Johnson & Johnson, CryoLife, Inc., Advanced Medical Solutions Group plc, Cohera Medical, Inc., Integra LifeSciences Corporation, Pfizer, Inc., C.R. Bard, Inc., Cohesion Technologies, Inc., Zimmer Biomet, and B. Braun Medical, Inc.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key questions are answered in this report.

  • What is the current status of the global hemostasis and tissue sealing agents market, and how will the global market progress through the forecast period?
  • What are the major market drivers and challenges prevalent in the global hemostasis and tissue sealing agents market?
  • What are the key market opportunities available to market participants?
  • Where will the market for tissue sealing agents be in 2026?
  • How are the major market players shaping their strategies for retaining or augmenting their competitive edge?
  • Which regional market will undergo the fastest market growth during the forecast period?
  • Will the rapid advances of the Asia-Pacific market threaten the positions of North America and Europe?
  • What is the current status of the competitive landscape of the global hemostasis and tissue sealing agents market?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global HTSA Market Portraiture
2.2. Global HTSA Market, by Product, 2017 (US$ Mn)
2.3. Global HTSA Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Hemostasis and Tissue Sealing Agents (HTSA) Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global HTSA Market, by Key Players, 2017

Chapter 4. Global Hemostasis and Tissue Sealing Agents (HTSA) Market, by Product, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Hemostats
4.2.1. Mechanical
4.2.2. Active
4.2.3. Flowable
4.3. Sealants
4.3.1. Fibrin Sealants
4.3.2. Synthetic Sealants, PEG-based
4.4. Adhesives
4.4.1. Cyanoacrylate
4.4.2. Albumin and Glutaraldehyde

Chapter 5. Global Hemostasis and Tissue Sealing Agents (HTSA) Market, by Geography, 2016 – 2026 (US$ Mn)
5.1. Overview
5.1.1. North America HTSA Market, 2016-2026 (US$ Mn)
5.1.2. North America HTSA Market, by Product, 2016 – 2026 (US$ Mn)
5.1.3. North America HTSA Market, by Country, 2016 – 2026 (US$ Mn)
5.1.3.1. U.S.
5.1.3.2. Canada
5.2. Europe HTSA Market, 2016 – 2026 (US$ Mn)
5.2.1. Europe HTSA Market, by Product, 2016 – 2026 (US$ Mn)
5.2.2. Europe HTSA Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.2.2.1. U.K.
5.2.2.2. Germany
5.2.2.3. Rest of Europe
5.3. Asia Pacific HTSA Market, 2016 – 2026 (US$ Mn)
5.3.1. Asia Pacific HTSA Market, by Product, 2016 – 2026 (US$ Mn)
5.3.2. Asia Pacific HTSA Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. China
5.3.2.2. Japan
5.3.2.3. Rest of Asia Pacific
5.4. Latin America HTSA Market, 2016 – 2026 (US$ Mn)
5.4.1. Latin America HTSA Market, by Product, 2016 – 2026 (US$ Mn)
5.4.2. Latin America HTSA Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. Brazil
5.4.2.2. Mexico
5.4.2.3. Rest of Latin America
5.5. Middle East & Africa HTSA Market, 2016 – 2026 (US$ Mn)
5.5.1. Middle East & Africa HTSA Market, by Product, 2016 – 2026 (US$ Mn)
5.5.2. Middle East & Africa HTSA Market, by Region, 2016 – 2026 (US$ Mn)
5.5.2.1. GCC
5.5.2.2. Rest of Middle East & Africa

Chapter 6. Company Profiles
6.1. Baxter International, Inc.
6.1.1. Business Description
6.1.2. Financial Information (Subject to Data Availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Johnson & Johnson
6.3. CryoLife, Inc.
6.4. Advanced Medical Solutions Group plc
6.5. Cohera Medical, Inc.
6.6. Integra LifeSciences Corporation
6.7. Pfizer, Inc.
6.8. C R Bard Inc.
6.9. Cohesion Technologies Inc
6.10. Zimmer Biomet
6.11. B Braun Medical Inc.

List of Figures

FIG 1. Hemostasis and Tissue Sealing Agents (HTSA) Market: Research Methodology
FIG 2. Hemostasis/Coagulation Analyzers: Market Segmentation
FIG 3. Global HTSA Market, by Product, 2017 (US$ Mn)
FIG 4. Global HTSA Market, by Geography, 2017 (US$ Mn)
FIG 5. Attractive Investment Proposition, by Geography, 2017
FIG 6. Competitive Analysis: Global HTSA Market, by Key Players, 2017
FIG 7. Global Mechanical Hemostats Market, 2016-2026(US$ Mn)
FIG 8. Global Active Hemostats Market, 2016-2026 (US$ Mn)
FIG 9. Global Flowable Hemostats Market, 2016-2026 (US$ Mn)
FIG 10. Global Fibrin Sealants Market, 2016-2026 (US$ Mn)
FIG 11. Global Synthetic Sealants, PEG-based Market, 2016-2026 (US$ Mn)
FIG 12. Global Cyanoacrylate Adhesives Market, 2016-2026 (US$ Mn)
FIG 13. Global Albumin and Glutaraldehyde Adhesives Market, 2016-2026 (US$ Mn)
FIG 14. U.S. HTSA Market, 2016-2026 (US$ Mn)
FIG 15. Canada HTSA Market, 2016-2026 (US$ Mn)
FIG 16. U.K. HTSA Market, 2016-2026 (US$ Mn)
FIG 17. Germany HTSA Market, 2016-2026 (US$ Mn)
FIG 18. Rest of Europe HTSA Market, 2016-2026 (US$ Mn)
FIG 19. China HTSA Market, 2016-2026 (US$ Mn)
FIG 20. Japan HTSA Market, 2016-2026 (US$ Mn)
FIG 21. Rest of Asia Pacific HTSA Market, 2016-2026 (US$ Mn)
FIG 22. Brazil HTSA Market, 2016-2026 (US$ Mn)
FIG 23. Mexico Hemostasis and Tissue Sealing Agents
FIG 24. Market, 2016-2026 (US$ Mn)
FIG 25. Rest of Latin America HTSA Market, 2016-2026 (US$ Mn)
FIG 26. GCC HTSA Market, 2016-2026 (US$ Mn)
FIG 27. Rest of Middle East and Africa HTSA Market, 2016-2026 (US$ Mn)

List of Tables

TABLE 1 Global Hemostasis and Tissue Sealing Agents (HTSA) Market Portraiture
TABLE 2 Global HTSA Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 3 Global Hemostats Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global Tissue Sealants Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global Tissue Adhesives Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 North America HTSA Market, by Product, 2016 – 2026 (US$ Mn
TABLE 7 North America HTSA Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 Europe HTSA Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 9 Europe HTSA Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 10 Asia Pacific HTSA Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 11 Asia Pacific HTSA Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Latin America HTSA Market, by Product, 2016 – 2026 (US$ Mn
TABLE 13 Latin America HTSA Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 Middle East and Africa HTSA Market, by Product, 2016 – 2026 (US$ Mn)
TABLE 15 Middle East and Africa HTSA Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 16 Baxter International, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 CryoLife, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Advanced Medical Solutions Group plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 Cohera Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Integra LifeSciences Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Pfizer, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 C R Bard Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 Cohesion Technologies, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 Zimmer Biomet: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 B Braun Medical, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Frequently Asked Questions

What is the size of Hemostasis And Tissue Sealing Agents Market?

The market for Hemostasis And Tissue Sealing Agents Market is expected to reach US$ XX Mn in 2026.

What is the Hemostasis And Tissue Sealing Agents Market CAGR?

The Hemostasis And Tissue Sealing Agents Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Hemostasis And Tissue Sealing Agents Market?

The report is forecasted from 2018-2026.

What is the base year considered for Hemostasis And Tissue Sealing Agents Market?

The base year of this report is 2017.

Who are the major players in this market?

Baxter International, Inc., Johnson & Johnson, CryoLife, Inc., Advanced Medical Solutions Group plc, Cohera Medical, Inc., Integra LifeSciences Corporation, Pfizer, Inc., C.R. Bard, Inc., Cohesion Technologies, Inc., Zimmer Biomet, are some of the major players in the global market.

Vietnam Medical Laser Market

Published:
Report ID: 38377

Atrial Fibrillation Devices Market

Published:
Report ID: 2420

Atherectomy Devices Market

Published:
Report ID: 2391

US Pharmacy Automation Market

Published:
Report ID: 38274

Veterinary Hematology Analyzers Market

Published:
Report ID: 11808

Franz Cell and Vapometer Market

Published:
Report ID: 37491

Europe Elderly Care Services Market

Published:
Report ID: 37291

Blood and Fluid Warming Systems Market

Published:
Report ID: 2312

India Wound Care Market

Published:
Report ID: 37156

Negative Pressure Wound Therapy Market

Published:
Report ID: 14408

Smart Insulin Pens Market

Published:
Report ID: 37000

Ophthalmic Viscoelastic Devices Market

Published:
Report ID: 36996

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN